{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:18:58Z","timestamp":1772248738956,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,4,10]],"date-time":"2010-04-10T00:00:00Z","timestamp":1270857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s10067-010-1405-7","type":"journal-article","created":{"date-parts":[[2010,4,9]],"date-time":"2010-04-09T11:53:15Z","timestamp":1270813995000},"page":"947-955","source":"Crossref","is-referenced-by-count":42,"title":["A systematic review of the effect of TNF-\u03b1 antagonists on lipid profiles in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"29","author":[{"given":"Eduardo Nicolas","family":"Pollono","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Lopez-Olivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Antonio Martinez","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E.","family":"Suarez-Almazor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,10]]},"reference":[{"issue":"4","key":"1405_CR1","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/art.10089","volume":"46","author":"S Doornum Van","year":"2002","unstructured":"Van Doornum S, McColl G, Wicks IP (2002) Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46(4):862\u2013873","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1405_CR2","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/art.20306","volume":"50","author":"M Boers","year":"2004","unstructured":"Boers M, Dijkmans B, Gabriel S, Maradit-Kremers H, O\u2019Dell J, Pincus T (2004) Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity. Arthritis Rheum 50(6):1734\u20131739","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1405_CR3","first-page":"1746","volume":"31","author":"WH Yoo","year":"2004","unstructured":"Yoo WH (2004) Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles. J Rheumatol 31(9):1746\u20131753","journal-title":"J Rheumatol"},{"issue":"3","key":"1405_CR4","first-page":"398","volume":"35","author":"G Kerekes","year":"2008","unstructured":"Kerekes G, Szekanecz Z, Der H, Sandor Z, Lakos G, Muszbek L et al (2008) Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 35(3):398\u2013406","journal-title":"J Rheumatol"},{"key":"1405_CR5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","volume":"14","author":"M Feldmann","year":"1996","unstructured":"Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397\u2013440","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"1405_CR6","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/art.20568","volume":"50","author":"EW St. Clair","year":"2004","unstructured":"St. Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P et al (2004) Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 50(11):3432\u20133443","journal-title":"Arthritis Rheum"},{"issue":"17","key":"1405_CR7","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","volume":"106","author":"D Hurlimann","year":"2002","unstructured":"Hurlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O et al (2002) Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106(17):2184\u20132187","journal-title":"Circulation"},{"issue":"Suppl 1","key":"1405_CR8","first-page":"66","volume":"37","author":"KR Feingold","year":"1998","unstructured":"Feingold KR, Hardardottir I, Grunfeld C (1998) Beneficial effects of cytokine induced hyperlipidemia. Z Ernahrungswiss 37(Suppl 1):66\u201374","journal-title":"Z Ernahrungswiss"},{"key":"1405_CR9","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses In: Institute OOHR, editor. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm"},{"issue":"2","key":"1405_CR10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/03009740500474578","volume":"35","author":"SR Dahlqvist","year":"2006","unstructured":"Dahlqvist SR, Engstrand S, Berglin E, Johnson O (2006) Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy. Scand J Rheumatol 35(2):107\u2013111","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"1405_CR11","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/rheumatology\/kem195","volume":"46","author":"F Porto Del","year":"2007","unstructured":"Del Porto F, Lagan\u00c3 B, Nofroni I, Tinti F, Mitterhofer AP, D\u2019Amelio R (2007) Effects of tumour necrosis factor alpha blockade on lipid profile in active rheumatoid arthritis [12]. Rheumatology 46(10):1626\u20131627","journal-title":"Rheumatology"},{"issue":"1","key":"1405_CR12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2004.04.031","volume":"177","author":"C Irace","year":"2004","unstructured":"Irace C, Mancuso G, Fiaschi E, Madia A, Sesti G, Gnasso A (2004) Effect of anti TNFalpha therapy on arterial diameter and wall shear stress and HDL cholesterol. Atherosclerosis 177(1):113\u2013118","journal-title":"Atherosclerosis"},{"issue":"2","key":"1405_CR13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/ard.2004.023119","volume":"64","author":"C Popa","year":"2005","unstructured":"Popa C, Netea MG, Radstake T, Van Der Meer JWM, Stalenhoef AFH, Van Riel PLCM et al (2005) Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Ann Rheum Dis 64(2):303\u2013305","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1405_CR14","first-page":"1997","volume":"34","author":"O Saiki","year":"2007","unstructured":"Saiki O, Takao R, Naruse Y, Kuhara M, Imai S, Uda H (2007) Infliximab but not methotrexate induces extra-high levels of VLDL-triglyceride in patients with rheumatoid arthritis. J Rheumatol 34(10):1997\u20132004","journal-title":"J Rheumatol"},{"key":"1405_CR15","doi-asserted-by":"crossref","unstructured":"Seriolo B, Paoliono S, Ferrone C, Cutolo M. Comments on the original article by Soubrier et al. Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis. Joint Bone Spine 2009;76(1):117\u2013118; author reply 118.","DOI":"10.1016\/j.jbspin.2008.09.004"},{"issue":"10","key":"1405_CR16","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s10067-007-0702-2","volume":"26","author":"B Seriolo","year":"2007","unstructured":"Seriolo B, Paolino S, Ferrone C, Cutolo M (2007) Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis. Clin Rheumatol 26(10):1799\u20131800","journal-title":"Clin Rheumatol"},{"issue":"1\u20132","key":"1405_CR17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cca.2005.08.010","volume":"365","author":"Y Allanore","year":"2006","unstructured":"Allanore Y, Kahan A, Sellam J, Ekindjian OG, Borderie D (2006) Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis. Clin Chim Acta 365(1\u20132):143\u2013148","journal-title":"Clin Chim Acta"},{"issue":"7","key":"1405_CR18","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10067-007-0803-y","volume":"27","author":"S Bosello","year":"2008","unstructured":"Bosello S, Santoliquido A, Zoli A, Di Campli C, Flore R, Tondi P et al (2008) TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. Clin Rheumatol 27(7):833\u2013839","journal-title":"Clin Rheumatol"},{"issue":"23\u201324","key":"1405_CR19","first-page":"1004","volume":"114","author":"E Cauza","year":"2002","unstructured":"Cauza E, Cauza K, Hanusch-Enserer U, Etemad M, Dunky A, Kostner K (2002) Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis. Wien Klin Wochenschr 114(23\u201324):1004\u20131007","journal-title":"Wien Klin Wochenschr"},{"issue":"6","key":"1405_CR20","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/ard.2007.078287","volume":"67","author":"SP Garces Da Gama","year":"2008","unstructured":"Garces Da Gama SP, Parreira Santos MJ, Vinagre FMR, Roque RM, Da Silva JAC (2008) Anti-tumour necrosis factor agents and lipid profile: a class effect? Ann Rheum Dis 67(6):895\u2013896","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1405_CR21","first-page":"309","volume":"24","author":"C Gonzalez-Juanatey","year":"2006","unstructured":"Gonzalez-Juanatey C, Llorca J, Sanchez Andrade A, Garcia-Porrua C, Martin J, Gonzalez-Gay MA (2006) Short-term adalimumab therapy improves endothelial function in patients with rheumatoid arthritis refractory to infliximab. Clin Exp Rheumatol 24(3):309\u2013312","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"1405_CR22","first-page":"921","volume":"33","author":"DN Kiortsis","year":"2006","unstructured":"Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA (2006) Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 33(5):921\u2013923","journal-title":"J Rheumatol"},{"issue":"1","key":"1405_CR23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1507\/endocrj.K07E-043","volume":"55","author":"K Nishida","year":"2008","unstructured":"Nishida K, Okada Y, Nawata M, Saito K, Tanaka Y (2008) Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody. Endocr J 55(1):213\u2013216","journal-title":"Endocr J"},{"issue":"19","key":"1405_CR24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1157\/13088951","volume":"126","author":"MJ Perez-Galan","year":"2006","unstructured":"Perez-Galan MJ, Salvatierra-Ossorio J, Caliz-Caliz R, Guzman-Ubeda MA (2006) Influence of tumor necrosis alpha blockade with infliximab on lipid profile in patients with active rheumatoid arthritis. Med Clin (Barc) 126(19):757","journal-title":"Med Clin (Barc)"},{"issue":"7","key":"1405_CR25","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/ard.2006.059691","volume":"66","author":"MJL Peters","year":"2007","unstructured":"Peters MJL, Vis M, Van Halm VP, Wolbink GJ, Voskuyl AE, Lems WF et al (2007) Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis. Ann Rheum Dis 66(7):958\u2013961","journal-title":"Ann Rheum Dis"},{"key":"1405_CR26","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/ard.2008.092171","volume":"68","author":"C Popa","year":"2009","unstructured":"Popa C, van Tits LJ, Barrera P, Lemmers HL, van den Hoogen FH, van Riel PL et al (2009) Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves HDL-cholesterol anti-oxidative capacity in rheumatoid arthritis patients. Ann Rheum Dis 68:868\u2013872","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1405_CR27","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/ard.2006.066191","volume":"66","author":"C Popa","year":"2007","unstructured":"Popa C, Van Den Hoogen FHJ, Radstake TRDJ, Netea MG, Eijsbouts AE, Den Heijer M et al (2007) Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis. Ann Rheum Dis 66(11):1503\u20131507","journal-title":"Ann Rheum Dis"},{"key":"1405_CR28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1196\/annals.1351.039","volume":"1069","author":"B Seriolo","year":"2006","unstructured":"Seriolo B, Paolino S, Sulli A, Fasciolo D, Cutolo M (2006) Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis. Ann N Y Acad Sci 1069:414\u2013419","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"1405_CR29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jbspin.2007.04.014","volume":"75","author":"M Soubrier","year":"2008","unstructured":"Soubrier M, Jouanel P, Mathieu S, Poujol D, Claus D, Dubost JJ et al (2008) Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis. Joint Bone Spine 75(1):22\u201324","journal-title":"Joint Bone Spine"},{"issue":"12","key":"1405_CR30","first-page":"2440","volume":"33","author":"E Spanakis","year":"2006","unstructured":"Spanakis E, Sidiropoulos P, Papadakis J, Ganotakis E, Katsikas G, Karvounaris S et al (2006) Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab. J Rheumatol 33(12):2440\u20132446","journal-title":"J Rheumatol"},{"issue":"9","key":"1405_CR31","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10067-007-0539-8","volume":"26","author":"LS Tam","year":"2007","unstructured":"Tam LS, Tomlinson B, Chu TT, Li TK, Li EK (2007) Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis. Clin Rheumatol 26(9):1495\u20131498","journal-title":"Clin Rheumatol"},{"issue":"2","key":"1405_CR32","first-page":"252","volume":"32","author":"M Vis","year":"2005","unstructured":"Vis M, Nurmohamed MT, Wolbink G, Voskuyl AE, De Koning MHMT, Van De Stadt RJ et al (2005) Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis. J Rheumatol 32(2):252\u2013255","journal-title":"J Rheumatol"},{"issue":"8","key":"1405_CR33","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/ard.2007.086728","volume":"68","author":"CA Wijbrandts","year":"2009","unstructured":"Wijbrandts CA, van Leuven SI, Boom HD, Gerlag DM, Stroes ES, Kastelein JJ et al (2009) Sustained changes in lipid profile and macrophage migration inhibitory factor (MIF) levels after anti-TNF therapy in rheumatoid arthritis. Ann Rheum Dis 68(8):1316\u20131321","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1405_CR34","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1002\/art.21397","volume":"52","author":"I Rincon Del","year":"2005","unstructured":"Del Rincon I, Freeman GL, Haas RW, O\u2019Leary DH, Escalante A (2005) Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 52(11):3413\u20133423","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1405_CR35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semarthrit.2004.11.007","volume":"35","author":"M Abu-Shakra","year":"2005","unstructured":"Abu-Shakra M, Polychuck I, Szendro G, Bolotin A, Jonathan BS, Flusser D et al (2005) Duplex study of the carotid and femoral arteries of patients with rheumatoid arthritis: a controlled study. Semin Arthritis Rheum 35(1):18\u201323","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"1405_CR36","first-page":"244","volume":"33","author":"S Grover","year":"2006","unstructured":"Grover S, Sinha RP, Singh U, Tewari S, Aggarwal A, Misra R (2006) Subclinical atherosclerosis in rheumatoid arthritis in India. J Rheumatol 33(2):244\u2013247","journal-title":"J Rheumatol"},{"issue":"11","key":"1405_CR37","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.11327","volume":"48","author":"M Nagata-Sakurai","year":"2003","unstructured":"Nagata-Sakurai M, Inaba M, Goto H, Kumeda Y, Furumitsu Y, Inui K et al (2003) Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthritis Rheum 48(11):3061\u20133067","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1405_CR38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijcard.2006.12.032","volume":"124","author":"SP Zhao","year":"2008","unstructured":"Zhao SP, Yang J, Li J, Dong SZ, Wu ZH (2008) Effect of niacin on LXRalpha and PPARgamma expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits. Int J Cardiol 124(2):172\u2013178","journal-title":"Int J Cardiol"},{"issue":"1\u20132","key":"1405_CR39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cca.2007.11.025","volume":"389","author":"SP Zhao","year":"2008","unstructured":"Zhao SP, Dong SZ (2008) Effect of tumor necrosis factor alpha on cholesterol efflux in adipocytes. Clin Chim Acta 389(1\u20132):67\u201371","journal-title":"Clin Chim Acta"},{"issue":"6","key":"1405_CR40","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.56.6.374","volume":"56","author":"R Munro","year":"1997","unstructured":"Munro R, Morrison E, McDonald AG, Hunter JA, Madhok R, Capell HA (1997) Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis 56(6):374\u2013377","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1405_CR41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9343(02)01186-5","volume":"113","author":"YB Park","year":"2002","unstructured":"Park YB, Choi HK, Kim MY, Lee WK, Song J, Kim DK et al (2002) Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med 113(3):188\u2013193","journal-title":"Am J Med"},{"issue":"4","key":"1405_CR42","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/ard.2008.101964","volume":"68","author":"E Choy","year":"2009","unstructured":"Choy E, Sattar N (2009) Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Ann Rheum Dis 68(4):460\u2013469","journal-title":"Ann Rheum Dis"},{"key":"1405_CR43","doi-asserted-by":"crossref","unstructured":"Toms TE, Symmons DP, Kitas GD (2010). Dyslipidaemia in Rheumatoid Arthritis: the Role of Inflammation, Drugs, Lifestyle and Genetic Factors. Curr Vasc Pharmacol (in press)","DOI":"10.2174\/1570209197581151611"},{"issue":"18","key":"1405_CR44","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","volume":"302","author":"E Angelantonio Di","year":"2009","unstructured":"Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A et al (2009) Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302(18):1993\u20132000","journal-title":"JAMA"},{"key":"1405_CR45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1476-511X-8-52","volume":"8","author":"J Ronald","year":"2009","unstructured":"Ronald J, Rajagopalan R, Ranchalis JE, Marshall JK, Hatsukami TS, Heagerty PJ et al (2009) Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease. Lipids Health Dis 8:52","journal-title":"Lipids Health Dis"},{"issue":"3","key":"1405_CR46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10067-007-0806-8","volume":"27","author":"KI Paraskevas","year":"2008","unstructured":"Paraskevas KI (2008) Statin treatment for rheumatoid arthritis: a promising novel indication. Clin Rheumatol 27(3):281\u2013287","journal-title":"Clin Rheumatol"},{"issue":"21","key":"1405_CR47","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM Jr, Kastelein JJP et al (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359(21):2195\u20132207","journal-title":"N Engl J Med"},{"issue":"4","key":"1405_CR48","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/ard.2008.091967","volume":"68","author":"SS Jick","year":"2009","unstructured":"Jick SS, Choi H, Li L, McInnes IB, Sattar N (2009) Hyperlipidemia, statin use and the risk of developing rheumatoid arthritis. Ann Rheum Dis 68(4):546\u2013551","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1405-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-010-1405-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1405-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T19:08:00Z","timestamp":1685560080000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-010-1405-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,10]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["1405"],"URL":"https:\/\/doi.org\/10.1007\/s10067-010-1405-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,10]]}}}